Phillip earned his PhD in Chemical Engineering from the University of Michigan in 2019. He worked in Jennifer Linderman’s research group and focused on the development of mechanistic computational models to study cancer cell signaling, heterogeneity, and chemokine gradients with relevance to cancer metastasis. In collaboration with imaging experts in Radiology, the work uncovered mechanisms that drive cancer cells in homogeneous environments to heterogeneously activate downstream signaling effectors and predicted how certain targeted therapies may inadvertently potentiate pro-metastatic signaling. Phillip earned his BS in Chemical Engineering from Clarkson University in Potsdam, NY in 2014.During his studies, Phillip completed internships at Genentech (2013) and Boehringer Ingelheim (2017) to gain hands-on experience and to learn how chemical engineers can impact drug research and development.

Interested in speaking with an expert?

We'll put you in touch with the right person on our team. 

Schedule Brief Consultation